To study radioresistance in esophageal adenocarcinoma, we generated an isogenic cell line model by exposing OE33 esophageal adenocarcinoma cells to clinically relevant fractionated doses of radiation (cumulative dose 50 Gy). A clonogenic assay confirmed enhanced survival of the radioresistant OE33 subline (OE33 R). To our knowledge, we are the first to generate an isogenic model of radioresistance in esophageal adenocarcinoma. This model system was characterized in terms of growth, cell cycle distribution and checkpoint operation, apoptosis, reactive oxygen species generation and scavenging, and DNA damage. While similar properties were found for both the parental OE33 (OE33 P) cells and radioresistant OE33 R cells, OE33 R cells demonstrated greater repair of radiation-induced DNA damage. Our results suggest that the radioresistance of OE33 R cells is due at least in part to increased DNA repair.
Niamh Lynam-Lennon, John V Reynolds, Graham P Pidgeon, Joanne Lysaght, Laure Marignol, and Stephen G Maher
Download Paper
Intuitive Advanced Radiation Planning for SARRP using SmART-XPS
SmART-XPS is a Monte Carlo based Treatment Planning Software developed and optimised for use on the SARRP platform. This webcast focuses on the intuitive yet advanced irradiation planning capabilities for the Xstrahl SARRP and highlights the roadmap for 2025 of new...